SunBio,Inc.

₩4,980As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:067370Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.55%)
Div yield 1.51%
ROE 35.40%
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.56
PE TTM 19.97
TSR TTM (8.62%)
Mkt cap ₩60.82B
ROIC 13.66%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩4,821
(3.19%)
30.05%
Hold 5|12|5|6|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
113.33
117.63
118.35
129.47
19.76%
19.95%
8.56%
10.64%
Revenue₩B
3.168
3.202
3.245
3.150
4.27%
3.26%
5.62%
0.79%
Peers (US$44.84M)
Cap (US$)
PE
45.74M
8.277x
44.91M
—
39.01M
—
Capital
TTM
5Y
10Y
Leveragex
3.474
1.778
1.282
EBIT/Intx
1.411
0.196
0.199
Own earn%
(40.51)
(16.52)
(7.75)
Sh yield%
34.60
22.39
23.07
Owners
Insiders/Inst%
10.71
74.86
Short interest%
2.01
SBC / revenue%
5.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
8–15
$1 testx
—
Incr. ROIC%
1